Sponsor Pipeline

Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
1
Phase 3
4
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04724369 Open-Label Study of 18F-mFBG for Imaging Neuroblastoma Neuroblastoma Active, Not Recruiting
Phase 2
NCT06965621 18F-mFBG Imaging for Myocardial Sympathetic Innervation Heart Failure Recruiting
NCT07176286 18F-mFBG Cardiac Uptake With Lewy Body Dementia Parkinson Disease (PD) Recruiting
Phase 1/2
NCT04535193 Open-Label Study of 18F-mFBG for Imaging Myocardial Sympathetic Innervation Cardiovascular Diseases Active, Not Recruiting
Disease Areas
Heart Disease (1) Heart Failure (1) Dementia (1) Parkinson's Disease (1)
Get alerts when Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free